• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Quantum Health to Acquire Embold Health, Strengthening AI-Powered Healthcare Navigation

by Fred Pennic 06/04/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– Quantum Health (“Quantum”), the creator of healthcare navigation, today announced it has signed a definitive agreement to acquire Embold Health (“Embold”), a leading physician-led healthcare technology company. 

– The strategic acquisition aims to deepen Quantum’s investment in AI-powered personalization, significantly enhancing its Real-Time Intercept® (RTI) and provider engagement capabilities. 

– The combination aims to guide members to cost-effective, high-quality care more effectively, thereby driving a stronger return on investment for clients. Together, Quantum and Embold will offer an expanded portfolio of products to the market.

Elevating Healthcare Navigation with AI and Physician-Level Analytics

The acquisition builds on a strong existing partnership between the two organizations. By pairing Embold’s proven provider quality analytics and conversational AI capabilities with Quantum’s 26-year legacy of navigation expertise and robust provider relationships, the combined entity is poised to redefine how consumers engage with healthcare.

“By joining forces, we’re not just adding technology — we’re elevating the standard for healthcare navigation,” said Dayne Williams, CEO of Quantum. “Our Healthcare Warriors®, already known for their compassion and expertise, will be equipped with even more powerful tools to guide members to the best care. When you combine our high provider and member Net Promoter Scores® (NPS) with Embold’s AI, you get a complete, intelligent and human-centered navigation experience built to deliver ROI”.

Embold Health: A Leader in Provider Quality Analytics and Responsible AI

Embold Health helps employers and health plans improve outcomes and lower costs by empowering members to make informed healthcare decisions. The company is known for its patented and peer-reviewed provider quality score methodology, which analyzes data from over 230 million individuals across 21 specialties and 68 sub-specialties at the individual physician performance level. Embold also utilizes conversational AI to simplify the care-seeking process, setting a standard for responsible AI in healthcare.

Enhanced Member Guidance

As part of the acquisition, Embold Health will continue to operate as an independent entity, maintaining its commitment to delivering exceptional service to its clients. With enhanced investment and resources from Quantum, Embold will accelerate the advancement of its product roadmap, further strengthening its ability to serve clients with innovative, data-driven solutions. 

By integrating Embold’s proprietary physician-level analytics and AI-powered provider recommendation engine, Quantum aims to deliver the most complete navigation experience in the industry—one that effectively balances trust, quality, and action. The combined company will serve more than 8 million members nationwide, significantly increasing the scale and scope of its products and capabilities.

Dr. Daniel Stein, CEO and Founder of Embold, will transition to the role of President of Embold.

“This is about bringing together two companies with shared missions,” said Dr. Stein. “Together, we remain focused on delivering the trusted insights our clients count on, with enhanced capabilities to help even more members access higher-quality care”.

Financial terms of the acquisition were not disclosed. The transaction is expected to close within the next 14 days, subject to customary closing conditions and regulatory approvals. Financial advisors for the transaction were Raymond James & Associates, Inc. for Embold Health and legal counsel was provided by Mayer Brown LLP for Embold Health and Kirkland & Ellis LLP for Quantum.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence, Healthcare Mergers & Acquisitions

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |